Site Search

... prevent cancer and protect survivors and their families. This year our focus will be on access to care and expanding access to comprehensive biomarker testing. Biomarker testing is an important step for accessing precision medicine, including targeted therapies that can lead to improved survivorship and ...

... to quit. We will be making the following fact-based policies a priority and ask for your support: Ensuring Access to Quality Care Access to Biomarker Testing: ACS CAN will advocate for improved coverage of comprehensive biomarker testing. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a ...

... to prioritize passing legislation to ease the burden of cancer on Buckeyes.  “ACS CAN calls on the legislature to increase access to biomarker testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments by ensuring state regulated health insurance, including Medicaid, covers appropriate biomarker testing for patients who could benefit. Dubbed ‘the right treatment at the right time,’ precision medicine has played a critical role ...

... contributions to the fight against cancer and leadership on the successful passage of first-in-the-nation legislation for comprehensive biomarker testing. "A longtime and established champion of health care issues, Leader Flowers again took on a leading role to help ensure cancer patients can ... of cancer-related public policy advocacy. "For Illinoisans with serious diseases like cancer, Leader Flowers knew that we must improve access to biomarker testing to make sure they are receiving the best treatment possible," said Shana Crews, ACS CAN government relations director. "Leader ...